Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort.

Stratmann B, Xu T, Meisinger C, Menart B, Roden M, Herder C, Grallert H, Peters A, Koenig W, Illig T, Wichmann HE, Wang-Sattler R, Rathmann W, Tschoepe D.

Cardiovasc Diabetol. 2014 May 5;13:90. doi: 10.1186/1475-2840-13-90.

2.

Association between hemoglobin A1c and all-cause mortality: results of the mortality follow-up of the German National Health Interview and Examination Survey 1998.

Paprott R, Schaffrath Rosario A, Busch MA, Du Y, Thiele S, Scheidt-Nave C, Heidemann C.

Diabetes Care. 2015 Feb;38(2):249-56. doi: 10.2337/dc14-1787. Epub 2014 Nov 20.

PMID:
25414153
3.

Impaired glucose metabolism among those with and without diagnosed diabetes and mortality: a cohort study using Health Survey for England data.

Gordon-Dseagu VL, Mindell JS, Steptoe A, Moody A, Wardle J, Demakakos P, Shelton NJ.

PLoS One. 2015 Mar 18;10(3):e0119882. doi: 10.1371/journal.pone.0119882. eCollection 2015.

4.

Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: the KORA S4/F4 Study.

Rathmann W, Kowall B, Tamayo T, Giani G, Holle R, Thorand B, Heier M, Huth C, Meisinger C.

Ann Med. 2012 Mar;44(2):170-7. doi: 10.3109/07853890.2010.531759. Epub 2010 Nov 22.

PMID:
21091229
5.

Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany.

Schöttker B, Brenner H, Koenig W, Müller H, Rothenbacher D.

Prev Med. 2013 Nov;57(5):596-600. doi: 10.1016/j.ypmed.2013.08.002. Epub 2013 Aug 13.

PMID:
23948106
6.

The mean platelet volume is significantly associated with higher glycated hemoglobin in a large population of unselected outpatients.

Lippi G, Salvagno GL, Nouvenne A, Meschi T, Borghi L, Targher G.

Prim Care Diabetes. 2015 Jun;9(3):226-30. doi: 10.1016/j.pcd.2014.08.002. Epub 2014 Sep 22.

PMID:
25249479
7.

Categories of glucose tolerance and continuous glycemic measures and mortality.

Kowall B, Rathmann W, Heier M, Giani G, Peters A, Thorand B, Huth C, Icks A, Meisinger C.

Eur J Epidemiol. 2011 Aug;26(8):637-45. doi: 10.1007/s10654-011-9609-y. Epub 2011 Jul 23.

PMID:
21785986
8.

Evaluation of four novel genetic variants affecting hemoglobin A1c levels in a population-based type 2 diabetes cohort (the HUNT2 study).

Hertel JK, Johansson S, Ræder H, Platou CG, Midthjell K, Hveem K, Molven A, Njølstad PR.

BMC Med Genet. 2011 Feb 4;12:20. doi: 10.1186/1471-2350-12-20.

9.

Are diabetes risk scores useful for the prediction of cardiovascular diseases? Assessment of seven diabetes risk scores in the KORA S4/F4 cohort study.

Kowall B, Rathmann W, Bongaerts B, Thorand B, Belcredi P, Heier M, Huth C, Rückert IM, Stöckl D, Peters A, Meisinger C.

J Diabetes Complications. 2013 Jul-Aug;27(4):340-5. doi: 10.1016/j.jdiacomp.2013.03.004. Epub 2013 May 7.

PMID:
23659777
10.

Intake of Vitamin and Mineral Supplements and Longitudinal Association with HbA1c Levels in the General Non-Diabetic Population--Results from the MONICA/KORA S3/F3 Study.

Schwab S, Zierer A, Heier M, Fischer B, Huth C, Baumert J, Meisinger C, Peters A, Thorand B.

PLoS One. 2015 Oct 16;10(10):e0139244. doi: 10.1371/journal.pone.0139244. eCollection 2015.

11.

Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.

Gardemann A, Humme J, Stricker J, Nguyen QD, Katz N, Philipp M, Tillmanns H, Hehrlein FW, Rau M, Haberbosch W.

Thromb Haemost. 1998 Aug;80(2):214-7.

PMID:
9716139
12.

Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients.

Ok ES, Asci G, Toz H, Ritz E, Kircelli F, Sever MS, Ozkahya M, Sipahi S, Dheir H, Bozkurt D, Omer Z, Sahin OZ, Ertilav M, Ok E.

Clin Nephrol. 2014 Sep;82(3):173-80.

PMID:
25079862
13.

Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease.

Addad F, Elalamy I, Chakroun T, Abderrazek F, Dridi Z, Hamdi S, Hassine M, Ben-Farhat M, Gerotziafas G, Hatmi M, Gamra H.

Blood Coagul Fibrinolysis. 2010 Oct;21(7):674-8. doi: 10.1097/MBC.0b013e32833e47c1.

PMID:
20739877
14.

The impact of metabolic control and QTc prolongation on all-cause mortality in patients with type 2 diabetes and foot ulcers.

Fagher K, Löndahl M.

Diabetologia. 2013 May;56(5):1140-7. doi: 10.1007/s00125-013-2860-x. Epub 2013 Feb 12.

PMID:
23404446
15.

Screening for HbA1c-defined prediabetes and diabetes in an at-risk greek population: performance comparison of random capillary glucose, the ADA diabetes risk test and skin fluorescence spectroscopy.

Tentolouris N, Lathouris P, Lontou S, Tzemos K, Maynard J.

Diabetes Res Clin Pract. 2013 Apr;100(1):39-45. doi: 10.1016/j.diabres.2013.01.002. Epub 2013 Jan 28.

PMID:
23369230
16.

Association Between Glycosylated Hemoglobin and Cardiovascular Events and Mortality in Older Adults without Diabetes Mellitus in the General Population: The Leiden 85-Plus Study.

Birkenhäger-Gillesse EG, den Elzen WP, Achterberg WP, Mooijaart SP, Gussekloo J, de Craen AJ.

J Am Geriatr Soc. 2015 Jun;63(6):1059-66. doi: 10.1111/jgs.13457. Epub 2015 Jun 1.

PMID:
26032644
17.

Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: a meta-analysis.

Hill CJ, Maxwell AP, Cardwell CR, Freedman BI, Tonelli M, Emoto M, Inaba M, Hayashino Y, Fukuhara S, Okada T, Drechsler C, Wanner C, Casula A, Adler AI, Lamina C, Kronenberg F, Streja E, Kalantar-Zadeh K, Fogarty DG.

Am J Kidney Dis. 2014 Jan;63(1):84-94. doi: 10.1053/j.ajkd.2013.06.020. Epub 2013 Aug 16.

PMID:
23958400
18.

Type 2 diabetes mellitus in Augsburg--an epidemiological overview.

Meisinger C, Döring A, Heier M, Thorand B, Löwel H; MONICA/KORA Study Group.

Gesundheitswesen. 2005 Aug;67 Suppl 1:S103-9.

PMID:
16032526
19.
20.

Effect of the PPARG2 Pro12Ala polymorphism and clinical risk factors for diabetes mellitus on HbA1c in the Japanese general population.

Hara M, Higaki Y, Taguchi N, Shinchi K, Morita E, Naito M, Hamajima N, Takashima N, Suzuki S, Nakamura A, Ohnaka K, Uemura H, Nishida H, Hosono S, Mikami H, Kubo M, Tanaka H; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.

J Epidemiol. 2012;22(6):523-31. doi: 10.2188/jea.JE20120078. Epub 2012 Sep 22.

Items per page

Supplemental Content

Write to the Help Desk